SLC5A2 and type 1 diabetes mellitus: Vallon et al. have shown that SGLT2 knockout attenuated hyperglycemia and glomerular hyperfiltration, but not renal injury, oxidative stress and inflammation in the streptozotocin (STZ)-induced type 1 diabetes model [28].